SMO and chronic myelogenous leukemia, BCR-ABL1 positive: HH signaling pathway was upregulated in CD34+ hematopoietic cells from patients with chronic myelomonocytic leukemia (CML).306,307 HH signaling pathway is increased in BCR-ABL+ progenitor cells in CML through enhanced expression of Smo.